Player FMアプリでオフラインにしPlayer FMう!
Christopher J. Moreau: DMT, Neuroplasticity & Stroke Recovery | Episode 200
Manage episode 349098991 series 2937889
Mr. Moreau is the CEO of Algernon Pharmaceuticals Inc. and a member of the company's board of directors. With over 30 years of executive management experience overall, including 15 years in CEO roles, he has proven achievements in operations management, acquisitions, licensing, and integration.
Algernon Pharmaceuticals plans to be the first Company globally to pursue DMT for stroke in humans and is planning to begin a clinical trial as soon as possible this year. DMT is a "classic" psychedelic compound part of the tryptamine family.
https://algernonpharmaceuticals.com
226 つのエピソード
Manage episode 349098991 series 2937889
Mr. Moreau is the CEO of Algernon Pharmaceuticals Inc. and a member of the company's board of directors. With over 30 years of executive management experience overall, including 15 years in CEO roles, he has proven achievements in operations management, acquisitions, licensing, and integration.
Algernon Pharmaceuticals plans to be the first Company globally to pursue DMT for stroke in humans and is planning to begin a clinical trial as soon as possible this year. DMT is a "classic" psychedelic compound part of the tryptamine family.
https://algernonpharmaceuticals.com
226 つのエピソード
सभी एपिसोड
×プレーヤーFMへようこそ!
Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。